文献速递胃肠动力与功能性疾病消化内镜

胃经口内镜下幽门肌切开术联合胃窦幽门肌切开术治疗难治性胃轻瘫:中期随访及预测疗效的因素

G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome.
PubMed 文献 · Aliment Pharmacol Ther · 2017-05-15

单中心研究纳入29例难治性胃轻瘫患者,行胃经口内镜下幽门肌切开术(G-POEM)联合胃窦幽门肌切开术,技术成功率100%,3个月临床成功率79%、6个月69%,平均胃轻瘫主要症状指数(GCSI)较术前显著下降,胃排空显像正常化70%。结论认为6个月中期疗效约70%,操作可重复且安全,糖尿病和女性为预测失败因素。

要点

  • 3个月临床成功率79%,6个月69%,平均GCSI由术前3.3±0.9降至1±1.2和1.1±0.9。
  • 胃排空显像(n=23)70%正常化,21%的病例存在不一致。
  • 单因素分析中糖尿病和女性与失败风险显著相关,多因素分析未证实。

核心结论

  • G-POEM的中期疗效在6个月时达到70%,该操作可重复且安全,糖尿病和女性是预测失败的因素。

研究设计与样本

  • 单中心研究,纳入2014年1月至2016年4月间接受手术的29例患者,均有胃排空显像(GES)异常和/或胃轻瘫主要症状指数(GCSI)升高。

主要发现

  • 共10名男性、19名女性,平均年龄52.8±18岁;技术成功率100%,平均手术时间47分钟。
  • 出现2例并发症,均经保守处理:1例出血和1例脓肿;中位随访10±6.4个月。
  • 3个月临床成功率79%,6个月69%,平均GCSI较术前显著下降(分别为3.3±0.9 vs 1±1.2和1.1±0.9)。
  • GES(n=23)在70%的病例中正常化,平均半排空时间和2小时残留显著改善,21%的病例存在不一致。
  • 单因素分析中糖尿病和女性与失败风险显著相关,多因素分析未证实。

局限性

  • 单因素分析中糖尿病和女性与失败风险显著相关,但多因素分析未证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric peroral endoscopic pyloromyotomy (G-POEM) was introduced for treating refractory gastroparesis. AIM: To present a series of patients focussed on clinical mid-term efficacy and predictive outcomes factors. METHODS: This was a single centre study of 29 patients operated on between January 2014 and April 2016, with disturbed gastric emptying scintigraphy (GES) and/or elevated Gastroparesis Cardinal Symptoms Index (GCSI). The procedures were performed as previously described. The primary endpoint was the efficacy at 3 and 6 months, based on GCSI and symptoms. The secondary endpoints were GES evolution, procedure reproducibility and safety, and identification of predictive factors for success. RESULTS: There were 10 men, 19 women (mean age 52.8±18). The technical success rate was 100% (average 47 minutes). There were two complications managed conservatively: one bleeding and one abscess. The median follow-up was 10±6.4 months. The clinical success rate was 79% at 3 months, 69% at 6 months, with a significant decrease in the mean GCSI compared to pre-operatively (3.3±0.9 vs 1±1.2 and 1.1±0.9 respectively). The GES (n=23) normalised in 70% of cases, with a significant improvement of the mean half emptying time and retention at 2 hours, and a discordance in 21% of the cases. In univariate analysis, diabetes and female gender were significantly associated with risk of failure, but not confirmed in multivariate analysis. CONCLUSIONS: The mid-term efficacy of G-POEM reaches 70% at 6 months. The procedure remains reproducible and safe. Diabetes and female gender were predictive of failure.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Gonzalez JM, Benezech A, Vitton V, et al. G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther. 2017. PMID: 28504312. doi:10.1111/apt.14132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。